Birth Defects Res A Clin Mol Teratol [PDF]
BackgroundLittle is known about the association between maternal autoimmune disease or its treatment and the risk of birth defects. We examined these associations using data from the National Birth Defects Prevention Study, a multi-site, population-based,
core
Non-tubal ectopic pregnancy: types of treatment and occurrence of severe complications in a university hospital. [PDF]
de Almeida AC +3 more
europepmc +1 more source
A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion. [PDF]
Jha N, Sagili H, Sharma J, Jha AK.
europepmc +1 more source
Outcomes of medical management of miscarriage in an early pregnancy setting. [PDF]
Elsayed S +5 more
europepmc +1 more source
Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions. [PDF]
Szpot P, Wachełko O, Zawadzki M.
europepmc +1 more source
Hormonal and electrolyte predictors for methotrexate versus surgery in ectopic pregnancy. [PDF]
Başkıran Y +3 more
europepmc +1 more source
The efficacy of mifepristone-misoprostol regimen versus misoprostol-only for medication abortion at 22 + 0/7 to 30 + 0/7 weeks' gestation. [PDF]
Touval O +5 more
europepmc +1 more source
Conservative methotrexate treatment of a scar pregnancy case: adding evidence to the evidence. [PDF]
Ligorio C +3 more
europepmc +1 more source
Distinguishing tubal rupture from tubal abortion in ectopic pregnancies after methotrexate treatment: a retrospective cohort study. [PDF]
Darwish A +5 more
europepmc +1 more source
Interstitial Pregnancy Managed with Single-dose Systemic Methotrexate: A Case Report. [PDF]
Basnet T, Yadav P, Sah MK, Yadav J.
europepmc +1 more source

